S.Korea says Russia's CoviVac COVID-19 vaccine seeks regulatory approval -drug safety ministry

by Reuters
Friday, 20 August 2021 07:26 GMT

SEOUL, Aug 20 (Reuters) - South Korea on Friday said Russia's COVID-19 vaccine CoviVac has applied for preliminary regulatory approval, the country's drug safety ministry said in a statement.

South Korea has not yet announced plans to make any purchases of CoviVac, the ministry said.

(Reporting by Sangmi Cha. Editing by Jane Merriman)

Our Standards: The Thomson Reuters Trust Principles.